Globitair

Stock market

Nvidia-Backed AI Biotech Iambic Up 16% After $150 Million IPO

BloombergUnited States of America

Iambic Therapeutics Inc. shares soared 16% in its trading debut after the clinical-stage cancer drugmaker and technology firm raised $150 million in a US initial public offering.

Read the full story at BloombergOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about United States of America

More on Stock market